eprintid: 10146936
rev_number: 6
eprint_status: archive
userid: 699
dir: disk0/10/14/69/36
datestamp: 2022-04-20 10:16:26
lastmod: 2022-04-20 10:16:26
status_changed: 2022-04-20 10:16:26
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Lo, J
creators_name: Forst, AL
creators_name: Warth, R
creators_name: Zdebik, AA
title: EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies
ispublished: pub
divisions: C08
divisions: G02
divisions: B02
divisions: UCL
divisions: D09
keywords: EAST syndrome, SeSAME syndrome, KCNJ10, KCNJ16, channelopathy, deafness, distal convoluted tubule, epilepsy
note: © 2022 Lo, Forst, Warth and Zdebik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
abstract: In 2009, two groups independently linked human mutations in the inwardly rectifying K+ channel Kir4.1 (gene name KCNJ10) to a syndrome affecting the central nervous system (CNS), hearing, and renal tubular salt reabsorption. The autosomal recessive syndrome has been named EAST (epilepsy, ataxia, sensorineural deafness, and renal tubulopathy) or SeSAME syndrome (seizures, sensorineural deafness, ataxia, intellectual disability, and electrolyte imbalance), accordingly. Renal dysfunction in EAST/SeSAME patients results in loss of Na+, K+, and Mg2+ with urine, activation of the renin–angiotensin–aldosterone system, and hypokalemic metabolic alkalosis. Kir4.1 is highly expressed in affected organs: the CNS, inner ear, and kidney. In the kidney, it mostly forms heteromeric channels with Kir5.1 (KCNJ16). Biallelic loss-of-function mutations of Kir5.1 can also have disease significance, but the clinical symptoms differ substantially from those of EAST/SeSAME syndrome: although sensorineural hearing loss and hypokalemia are replicated, there is no alkalosis, but rather acidosis of variable severity; in contrast to EAST/SeSAME syndrome, the CNS is unaffected. This review provides a framework for understanding some of these differences and will guide the reader through the growing literature on Kir4.1 and Kir5.1, discussing the complex disease mechanisms and the variable expression of disease symptoms from a molecular and systems physiology perspective. Knowledge of the pathophysiology of these diseases and their multifaceted clinical spectrum is an important prerequisite for making the correct diagnosis and forms the basis for personalized therapies.
date: 2022-03-15
date_type: published
publisher: Frontiers Media SA
official_url: https://doi.org/10.3389/fphys.2022.852674
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1949332
doi: 10.3389/fphys.2022.852674
medium: Electronic-eCollection
lyricists_name: Zdebik, Anselm
lyricists_id: AAZDE01
actors_name: Kalinowski, Damian
actors_id: DKALI47
actors_role: owner
full_text_status: public
publication: Frontiers in Physiology
volume: 13
article_number: 852674
event_location: Switzerland
issn: 1664-042X
citation:        Lo, J;    Forst, AL;    Warth, R;    Zdebik, AA;      (2022)    EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies.                   Frontiers in Physiology , 13     , Article 852674.  10.3389/fphys.2022.852674 <https://doi.org/10.3389/fphys.2022.852674>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10146936/1/Zdebik_EAST%3ASeSAME%20Syndrome%20and%20Beyond_VoR.pdf